Thus, the finding of elevated phenylacetone among both juvenile and aged APP mice in this study indicate a metabolic abnormality throughout the life span in these mice, consistent with altered metabolic properties in persons with AD (e.g.,59). This evidence concerns the gene APP and Alzheimer disease.